✦ LIBER ✦

Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trial

✍ Scribed by Burkes, Ronald L.; Shepherd, Frances A.; Blackstein, Martin E.; Goldberg, Melvin E.; Waters, Paul F.; Patterson, G. Alexander; Todd, Thomas; Pearson, F. Griffith; Jones, Donald; Farooq, Samina; McGlaughlin, John; Ginsberg, Robert J.

Book ID: 119319002
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 113 KB
Volume: 47
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2004.06.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-237 Combination of gemcitabine-paclita

P-237 Combination of gemcitabine-paclitaxel-cisplatin (GTP) as induction chemotherapy for unresectable stage IIIA(N2) non-small cell lung cancer (NSCLC): results of a multicenter phase II study

✍ Nelli, Fabrizio; De Marinis, Filippo; Migliorino, Maria Rita; Martelli, Olga; Tr 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Induction chemotherapy with cisplatin an

Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: Final results of a phase II study

✍ Blanco, Remei; Solé, Josep; Montesinos, Jesús; Mesía, Carlos; Algara, Manuel; Te 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 552 KB

Randomized study of vinorelbine (VRB) or

Randomized study of vinorelbine (VRB) or vindesine (VDS) with cisplatin (P) and mitomycin (M) as induction chemotherapy in stage IIIB or IV non-small cell lung cancer (NSCLC) — Final results

✍ Kawaguchi, T; Kawahara, M; Furuse, K; Nishiwaki, Y; Horai, T; Saijo, N; Hasegawa 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 107 KB

A phase II trial of individualized respo

A phase II trial of individualized response-based induction chemotherapy (IC) of mitomycin-C, vindesine, cisplatin (MVP) followed by thoracic radiotherapy (TRT) with daily low-dose carboplatin (CBDCA) for the treatment of unresectable stage III non-small-cell lung cancer (NSCLC)

✍ Shinbo, T; Makino, M; Tsukada, H; Yokoyama, A; Saitou, M; Kurita, Y 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 230 KB

PD-039 Induction chemotherapy with cispl

PD-039 Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation (CCR) with biweekly gemcitabine in unresectable stage III non small cell lung cancer (NSCLC): Final results of a phase II study

✍ Blanco, R.; Solé, J.; Nogué, M.; Montesinos, J.; Gallardo, E.; Vadell, C.; Mesía 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Gemcitabine and Cisplatin as induction r

Gemcitabine and Cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 Non-Small Cell Lung Cancer: A phase II study of the EORTC Lung Cancer Cooperative Group (EORTC 08955)

✍ Van Zandwijk, N; Smith, E.F; Kramer, G.W.P; Schramel, F; Gans, S; Festen, J; Ter 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 121 KB